Figure 6. The change of LDH leakage rate intervened with the DP agonists and antagonists.

(a) BW245C and (d) CAY10471 significantly decreased the LDH leakage rate in Al³⁺-treated groups. (b) BWA868C and (c) DK-PGD₂ increased the LDH leakage rate in Al³⁺-treated groups. Values were mean ± SD of four individual experiments (n = 4. ^##P < 0.01 compared with control group. **P < 0.01 compared with Al³⁺-treated group, one-way ANOVA with Dunnett’s multiple comparisons).